<p>Meta-analysis of the logs hazard ratios of overall survival comparing bevacizumab and standard therapy in all trials combined.</p
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1≥50%) of LABAs compared with placebo.</...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1<50%) of LABAs compared with placebo.</...
PURPOSE: To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival ...
<p>Meta-analysis of the log hazard ratios of progression free survival comparing bevacizumab and sta...
<p>Meta-analysis of the risk ratios of overall response rate comparing bevacizumab and standard ther...
<p>Bars, 95% confidence intervals (CI) of hazard ratio in patients receiving bevacizumab versus cont...
<p><b>Bars, 95% confidence intervals (CI) of hazard ratio in patients receiving bevacizumab versus c...
<p><b>Abbreviations:</b> PFS: progression free survival; OS: overall survival; ORR: overall response...
<p>Bars, 95% confidence intervals (CI) of odds ratio in patients receiving bevacizumab versus contro...
<p>Meta-analysis of adverse events rate ratio comparisons in controls and disulfiram treated patient...
<p>Meta-analysis of overall survival for S-1-based chemotherapy compared with capecitabine-based che...
To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patien...
To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patien...
<p>Meta-analysis of fatal cardiovascular events in RCTs of LABAs compare with placebo.</p
<p>Meta-analysis of fatal cardiovascular events in long-term RCTs of LABAs compared with placebo.</p
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1≥50%) of LABAs compared with placebo.</...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1<50%) of LABAs compared with placebo.</...
PURPOSE: To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival ...
<p>Meta-analysis of the log hazard ratios of progression free survival comparing bevacizumab and sta...
<p>Meta-analysis of the risk ratios of overall response rate comparing bevacizumab and standard ther...
<p>Bars, 95% confidence intervals (CI) of hazard ratio in patients receiving bevacizumab versus cont...
<p><b>Bars, 95% confidence intervals (CI) of hazard ratio in patients receiving bevacizumab versus c...
<p><b>Abbreviations:</b> PFS: progression free survival; OS: overall survival; ORR: overall response...
<p>Bars, 95% confidence intervals (CI) of odds ratio in patients receiving bevacizumab versus contro...
<p>Meta-analysis of adverse events rate ratio comparisons in controls and disulfiram treated patient...
<p>Meta-analysis of overall survival for S-1-based chemotherapy compared with capecitabine-based che...
To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patien...
To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patien...
<p>Meta-analysis of fatal cardiovascular events in RCTs of LABAs compare with placebo.</p
<p>Meta-analysis of fatal cardiovascular events in long-term RCTs of LABAs compared with placebo.</p
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1≥50%) of LABAs compared with placebo.</...
<p>Meta-analysis of fatal cardiovascular events in RCTs (FEV1<50%) of LABAs compared with placebo.</...
PURPOSE: To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival ...
DOI
Add to ORKG